ANTISERUM TO HUMAN HEMOPEXIN— 510(k) K790713

Name: FDA 510(k) clearance K790713
Creator: U.S. Food and Drug Administration
Published: 1979-09-04

Substantially Equivalent

Kent Laboratories, Inc.

FDA 510(k) clearance K790713 for ANTISERUM TO HUMAN HEMOPEXIN, Substantially Equivalent on 1979-09-04. Applicant: Kent Laboratories, Inc.. Device class: 2.

Clearance details

Applicant: Kent Laboratories, Inc.
Product code: Code CZX
Device class: Class 2
Regulation: 21 CFR 866.5490
Advisory panel: Immunology
Date received: 1979-04-12
Decision date: 1979-09-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CZX

view all

K801432 — HEMOPEXIN NEPHELOMETRIC ASSAY1980-07-08
K780250 — HEMOPEXIN NEPHELOMETRIC ASSAYS1978-02-28

More clearances from Kent Laboratories, Inc.

view all

K951966 — HUMAN PREALBUMIN RADIAL IMMUNODIFFUSION KIT1995-06-01
K951967 — HUMAN C1 INACTIVATOR OR C-1 ESTERASE INHIBITOR RADIAL IMMUNODIFFUSION KIT1995-05-30
K951968 — HUMAN C1Q RADIAL IMMUNODIFFUSION KIT1995-05-30
K950102 — HUMAN C-5 RADIAL IMMUNODIFFUSION KIT1995-04-10
K850683 — 72 DETERM. SIZE RADIAL IMMUNODIFFUSION TEST ALPHA21985-11-27

Data sourced from openFDA. This site is unofficial and independent of the FDA.